Venatorx Pharmaceuticals and GARDP Partner to Develop New Antibiotic for Hospital Acquired Infections with Limited Treatment Options
MALVERN, PA — Venatorx Pharmaceuticals and the Global Antibiotic Research and Development Partnership (GARDP) recently announced a collaboration to accelerate the development of, and access to, cefepime-taniborbactam (formerly cefepime/VNRX-5133).
Read More